Straumann Holding AG (STMN) AI Stock Analysis

• Market Cap: CHF16.50B
• Dividend Yield: 0.92%
• Average Volume (3M): 252.82K
• Price to Earnings (P/E): 43.2
• Beta (1Y): 1.37
• Revenue Growth: 3.82%
• EPS Growth: 57.08%
• Country: CH
• Employees: 11,342
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Instruments & Supplies
• EPS (TTM): N/A
• Shares Outstanding: 159,455,250
• 10 Day Avg. Volume: 235,997
• 30 Day Avg. Volume: 252,823
• PEG Ratio: 1.00
• Price to Book (P/B): 8.16
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 46.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF132.75
• Price Target Upside: 28.26% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 8

• Rating: 72 Outperform
• Price Target: CHF116.00 ▲(12.08%Upside)

Straumann Holding AG's stock score is driven by strong financial performance and positive earnings call highlights. The company's robust revenue growth and strategic innovations are significant strengths. However, the high valuation and mixed technical indicators present potential risks.

Positive Factors

Financial Performance

The company reported a strong start with top-line results beating expectations, indicating robust growth.

Market Expansion

Asia Pacific achieved a historical high in revenue with significant growth, driven by strong market performance.

Negative Factors

Economic Conditions

Macro and consumer picture in the US has worsened, potentially affecting Straumann's performance.

Regional Growth Concerns

There is concern over sequentially slower North American growth and a lack of clarity on aligner products.

Straumann Holding AG Business Overview & Revenue Model

Company Description

Straumann Holding AG (STMN) is a global leader in the field of implant, restorative, and regenerative dentistry. Based in Basel, Switzerland, the company operates within the healthcare sector, specifically focusing on the development and provision of dental implants, prosthetics, and digital solutions for dental professionals and laboratories. With a commitment to innovation and quality, Straumann offers a comprehensive range of products and services that enhance the quality of life for patients worldwide.

How the Company Makes Money

Straumann Holding AG generates revenue primarily through the sale of dental implants and prosthetic products. The company also earns income from its digital dentistry solutions, which include CAD/CAM systems, intraoral scanners, and 3D printing technologies. Additionally, Straumann offers regenerative products, such as biomaterials for oral tissue regeneration. The company collaborates with dental professionals and institutions globally, leveraging significant partnerships and distribution networks to expand its market reach. Factors such as a growing global demand for dental care, advancements in dental technology, and an aging population contribute to the company's earnings. Straumann's strategic acquisitions and investments in innovative technologies further bolster its revenue streams.

Straumann Holding AG Financial Statement Overview

Summary

Straumann Holding AG is in a strong financial position, with consistent revenue growth and profitability. The company maintains a healthy balance sheet with manageable debt levels. Cash flow is stable, supporting future growth. However, attention should be given to rising operational costs and liabilities.

Income Statement

Straumann Holding AG has demonstrated consistent revenue growth with a solid increase from 2023 to 2024. Gross Profit Margin is strong, indicating effective cost management. However, there is a slight decline in EBIT and EBITDA margins, suggesting rising operating costs or increased competition.

Balance Sheet

The company's balance sheet is stable with a moderate Debt-to-Equity ratio, reflecting balanced leverage. The Return on Equity is healthy, indicating efficient use of equity. The Equity Ratio is solid, showing a strong financial position, although the increase in total liabilities warrants monitoring.

Cash Flow

The cash flow is robust with a stable Free Cash Flow, reflecting the company's good cash generation capacity. There is a slight decline in Operating Cash Flow, which could be a sign of higher operational expenses. The Free Cash Flow to Net Income ratio is favorable, indicating efficient cash management.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.50B	2.41B	2.32B	2.02B	1.43B
Gross Profit	1.78B	1.79B	1.70B	1.53B	1.03B
EBITDA	726.15M	685.07M	685.37M	591.48M	230.45M
Net Income	388.32M	246.07M	434.79M	396.08M	91.28M
Balance Sheet
Total Assets	3.62B	3.40B	3.45B	3.05B	2.62B
Cash, Cash Equivalents and Short-Term Investments	383.07M	413.54M	697.11M	881.50M	632.49M
Total Debt	413.89M	412.35M	705.20M	711.66M	731.66M
Total Liabilities	1.58B	1.56B	1.60B	1.55B	1.41B
Stockholders Equity	2.04B	1.84B	1.85B	1.50B	1.20B
Cash Flow
Free Cash Flow	315.62M	316.61M	220.94M	440.97M	295.34M
Operating Cash Flow	483.39M	503.95M	416.38M	561.94M	377.41M
Investing Cash Flow	-352.62M	-349.33M	-449.84M	-185.20M	-145.64M
Financing Cash Flow	-169.06M	-424.40M	-140.35M	-122.90M	153.33M

Straumann Holding AG Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 103.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:STMN, the sentiment is Positive. The current price of 103.5 is below the 20-day moving average (MA) of 104.73, below the 50-day MA of 106.55, and below the 200-day MA of 113.51, indicating a neutral trend. The MACD of -0.19 indicates Negative momentum. The RSI at 51.96 is Neutral, neither overbought nor oversold. The STOCH value of 35.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:STMN.

Straumann Holding AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SOON	74 Outperform	CHF13.21B	25.36		1.91%	6.58%	-10.02%
YPSN	73 Outperform	CHF5.94B	66.29	13.49%	0.50%	36.54%	11.60%
ALC	73 Outperform	CHF34.37B	34.70	5.23%	0.41%	3.90%	6.76%
STMN	72 Outperform	CHF16.50B	43.23		0.92%	3.82%	57.08%
GALD	71 Outperform	CHF29.65B	144.42		0.12%	5.91%	―
TECN	61 Neutral	CHF2.12B	30.51	4.84%	1.81%	-13.04%	-48.74%
Sector *	52 Neutral	$7.47B	-0.04	-63.86%	2.34%	16.17%	0.25%

Straumann Holding AG Corporate Events

Straumann Group Announces Webcast for Half-Year Results 2025

Straumann Holding AG announced a webcast for their half-year results 2025, scheduled for August 13, 2025. The event targets investors, financial analysts, and media professionals, providing insights into the company’s business development and offering a platform for questions and answers with the management. This announcement highlights Straumann’s commitment to transparency and engagement with stakeholders, potentially impacting investor confidence and market perception.

The most recent analyst rating on (CH:STMN) stock is a Hold with a CHF143.00 price target. To see the full list of analyst forecasts on Straumann Holding AG stock, see the CH:STMN Stock Forecast page.

Straumann Announces Major Investment in Villeret Amid Strategic Shift to China

Straumann Holding AG has announced a strategic investment of 60 to 80 million CHF in its Villeret site over the next five years to enhance its role as a competence center for innovation and precision manufacturing. This investment will focus on advanced technologies and infrastructure modernization, while also addressing workforce adjustments due to the relocation of production for the Chinese market to a new campus in Shanghai. The move aims to secure competitiveness in China, which accounts for over 15% of Straumann’s global revenue, and ensure long-term growth and market positioning. The changes could affect up to 250 positions in Villeret, with a consultation process underway to explore socially acceptable solutions.

The most recent analyst rating on (CH:STMN) stock is a Buy with a CHF157.00 price target. To see the full list of analyst forecasts on Straumann Holding AG stock, see the CH:STMN Stock Forecast page.

Straumann Holding AG Reports Strong Q1 2025 Growth Amid Global Challenges

Straumann Holding AG reported a strong start to 2025 with a 11.0% organic sales growth in the first quarter, reaching CHF 680.7 million. The EMEA and APAC regions were notable for their contributions, with significant growth in China and the introduction of new products like the iEXCEL implant system. Despite macroeconomic uncertainties, Straumann’s diversified portfolio and strategic partnerships have positioned it well for continued success, as evidenced by positive responses at the International Dental Show and sustained growth in digital solutions and orthodontics.